NCT02473965: A reported trial by Grifols Therapeutics LLC
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02473965 |
|---|---|
| Title | A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of lGIV-C as a Corticosteroid Sparing Agent in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | June 30, 2015 |
| Completion date | Feb. 28, 2019 |
| Required reporting date | Feb. 28, 2020, midnight |
| Actual reporting date | Feb. 12, 2020 |
| Date last checked at ClinicalTrials.gov | Aug. 12, 2025 |
| Days late | None |